Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.

International clinical psychopharmacology - 1 Jan 2010

Dombrovski Alexandre Y, Mulsant Benoit H, Ferrell Robert E, Lotrich Francis E, Rosen Jules I, Wallace Meredith, Houck Patricia R, Mazumdar Sati, Pollock Bruce G

Abstract excerpt

The risk/benefit ratio of pharmacotherapy for behavioral symptoms of dementia is questionable: second-generation antipsychotics are poorly tolerated, and the efficacy of alternative treatments, for example, selective serotonin-reuptake inhibitors (SSRIs), is uncertain. Biomarkers of treatment response may improve this risk/benefit ratio. The length polymorphism of the serotonin transporter promoter gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Behavioral Symptoms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Citalopram

Share to Dementia

Share to Psychotic Disorders

Share to Risperidone

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin Plasma Membrane Transport Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 19996755
DOI: 10.1097/YIC.0b013e328333ee10
PMCID: PMC2887732

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.PMID 19996755Read ↗

Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms.Semantic proximity Read ↗

Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.Semantic proximity Read ↗

Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review.Semantic proximity Read ↗

Pharmacogenetics and the serotonin transporter in late-life depressionSemantic proximity Read ↗

Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in Italy.Semantic proximity Read ↗

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.Semantic proximity Read ↗

Common selective serotonin reuptake inhibitor side effects in older adults associated with genetic polymorphisms in the serotonin transporter and receptors: data from a randomized controlled trial.Semantic proximity Read ↗

Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.Semantic proximity Read ↗

Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach.Semantic proximity Read ↗

Association of the Serotonin Transporter and Receptor Gene Polymorphisms in Neuropsychiatric Symptoms in Alzheimer DiseaseSemantic proximity Read ↗

Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder.Semantic proximity Read ↗

The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.